Methocarbamol Injection
NDC Package 70436-149-55

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Methocarbamol injection is methocarbamol is used to treat muscle spasms/pain. This formulation utilizes a injection delivery system. Marketed by Slate Run Pharmaceuticals, Llc, this product is identified by NDC 70436-149 and is authorized under FDA application ANDA208116.

Identification & Billing

NDC Package Code
70436-149-55
Package Description
25 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (70436-149-33)
Product Code
70436-149
11-Digit Billing Format
70436014955
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Methocarbamol
Non-Proprietary Name
Methocarbamol
Substance Name
Methocarbamol
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
METHOCARBAMOL 100 mg/mL
Pharmacologic Class
Usage Information
Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Regulatory & Marketing

Labeler Name
Slate Run Pharmaceuticals, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA208116
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-01-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70436-149-55 identifies a specific commercial package of 25 vial, single-dose in 1 carton / 10 ml in 1 vial, single-dose (70436-149-33) of Methocarbamol, a human prescription drug labeled by Slate Run Pharmaceuticals, Llc. This injection is formulated for intravenous use and contains methocarbamol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Slate Run Pharmaceuticals, Llc on July 01, 2024. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

How is this Slate Run Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70436014955. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70436-149-55
11-Digit CMS (5-4-2)
70436-0149-55

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.